Background High-quality anticoagulation management is required to keep these narrow
therapeutic index medications as effective and safe as possible. This article focuses on the …

Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT)
and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, …

In July 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results. …

Background: Specificity in leukocyte trafficking is likely to depend on sequential interactions
between various cell-type-specific leukocyte adhesion molecules, such as selectins and …

Context A growing body of reports has documented the ability of anticoagulation management
services to help patients receiving warfarin therapy achieve better outcomes compared to …

Vital signs, including heart rate and body temperature, are useful in detecting or monitoring
medical conditions, but are typically measured in the clinic and require follow-up laboratory …

Prothrombin complex concentrates (PCCs) are recommended as the treatment of choice in
warfarin-related coagulopathy. However, the risk of thromboembolic complications …

Background Patients who not only survive a warfarin-associated gastrointestinal tract
bleeding (GIB) event but also have an ongoing risk for thromboembolism present 2 clinical …

Background : Severity of left atrial (LA) fibrosis is a strong predictor of atrial fibrillation (AF)
ablation success and has been associated with a history of stroke, hypertension, and heart …

Venous thromboembolism (VTE) is a serious and often fatal medical condition with an
increasing incidence. The treatment of VTE is undergoing tremendous changes with the …